Case Report
Spontaneous Tumor Lysis Syndrome in a Patient with a Dedifferentiated Endometrial Adenocarcinoma
Table 1
Laboratory tests upon admission.
| On admission | Fifth day | Reference range |
| Alb | 3.3 g/dL | Alb | 2.7 g/dL | 3.5–4.5 g/dL | AST | 16 IU/L | AST | 35 IU/L | 10–35 IU/L | ALT | 7 IU/L | ALT | 12 IU/L | 10–35 IU/L | LDH | 444 IU/L | LDH | 662 IU/L | 100–250 IU/L | BUN | 17.8 mg/dL | BUN | 66.4 mg/dL | <20 mg/dL | Cre | 1.52 mg/dL | Cre | 5.18 mg/dL | <0.80 mg/dL | Na | 126 mEq/L | Na | 126 mEq/L | 135–145 mEq/L | K | 4.9 mEq/L | K | 5.7 mEq/L | 3.5–4.5 mEq/L | Cl | 89 mEq/L | Cl | 83 mEq/L | 95–108 mEq/L | UA | 9.0 mg/dL | UA | 18.8 mEq/L | <6.8 mEq/L | CRP | 14.48 mg/dL | CRP | 27.6 mg/dL | <0.30 mEq/L | | | Ca | 10.0 mg/dL | 8.5–10.5 mg/dL | | | P | 9.3 mg/dL | 2.7–4.6 mg/dL | CEA | 5.7 ng/mL | | | 0–5 ng/mL | CA19-9 | 2294 IU/mL | | | 0–37 IU/mL | CA125 | 506 IU/mL | | 0–35 IU/mL | HTLV-1 antibody | Positive | | | Negative |
|
|